Published: Sun, January 06, 2019
Medical | By Vicki Mclaughlin

FDA Recall of Heart Meds Grows Due to Cancer Risk

FDA Recall of Heart Meds Grows Due to Cancer Risk

A full list of the recalled products is posted on the FDA's website.

Aurobindo Pharma USA, voluntarily recalling two lots of Valsartan tablets, 26 lots of amlodipine and Valsartan combination tablets, and 52 lots of Valsartan and hydrochlorothiazide (HCTZ) combination tablets. The agency stresses that not all valsartan and related products are under recall, only specific lots.

The FDA is advising patients prescribed these medications to continue to take them, as the health risks may be higher if the treatment is stopped immediately without any alternative treatment.

In November Mylan Pharmaceutics recalled several lots of blood pressure medicine that were also contaminated with N-nitrosodiethylamine.

In addition, a longer list of blood pressure drugs recalled in the past months can be found here.

Mother: Jazmine Barnes' killing was a hail of glass, bullets
The Sheldon Independent School District said in a statement that Jazmine was a second-grader at Monahan Elementary in Houston . Jazmine's mother , LaPorsha Washington , was one of those who spoke to the crowd, calling for justice for her daughter.

New York Yankees: David Robertson signs deal down I-95
Hector Neris is also an interesting wild card after losing his job as the team's closer early in the 2018 season. If you have ever seen Robertson pitch, you know he really is a two-pitch pitcher.

John Legend Calls R. Kelly "Serial Child Rapist"
ET/PT on Lifetime. "We should all thank my friend @dreamhampton for her very necessary work to create #SurvivingRKelly ". Tell us what you think! The series continues on Friday (January 5) and concludes on Saturday (January 6) at 9 p.m.

Losartan potassium tablets USP are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and nephropathy in Type 2 diabetic patients. BO31C016 and 4DK3C005 of Losartan Potassium USP tablets.

Instructions for returning recalled products are given in the recall letter. Consumers should contact their physician or healthcare provider if they have any problems associated with taking the medication.

"I recommend if the patients have any questions at all, whether they think they are affected or not, the pharmacist is a very accessible resource for them and they should call their local pharmacist if they have any concerns about their medication", says Dr. Ganio.

Adverse reaction or quality issues with the medication can be reported to the FDA's MedWatch Adverse Event Reporting program. Forms to mail or fax can be obtained at or by calling 1-800-332-1088.

Aurobindo Pharma recently stated that according to an IARC (International Agency for Research on Cancer) classification, the impurity NDEA discovered in the finished drug is a naturally-occurring substance found in drinking water, industrial processes, air pollution, and certain foods.

Like this: